Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
28 Results for "
C5 complement inhibitor
" in MedChemExpress (MCE) Product Catalog:
Products (28)
28 Results for "C5 complement inhibitor" in MCE Product Catalog:
5
Target:
Forschungsgebiete:
Avacopan (CCX168) is a potent, selective and orally available complement 5a receptor (C5aR) inhibitor with an IC50 of 0.1 nM.
5
5 Cited Publications
Target:
Forschungsgebiete:
JPE-1375 is a complement C5a receptor 1 (C5aR1) antagonist. JPE-1375 effectively inhibits polymorphonuclear leukocyte mobilization (EC50=6.9 μM) and reduces TNF levels (EC50=4.5 μM) in mice. JPE-1375 can be used in studies of autoimmune and inflammatory diseases .
4
4 Cited Publications
Art. -Nr.: HY-P9914
CAS. Nr.: 219685-50-4
Synonyms: Anti-Human C5, Humanized Antibody; h5G1.1
Target:
Forschungsgebiete:
Cardiovascular Disease Infection Neurological Disease Inflammation/Immunology
1
1 Cited Publications
Target:
Forschungsgebiete:
Compound C5-IN-1 (Compound 7) is a selective allosteric inhibitor of complement component protein C5. Compound C5-IN-1 prevents C5 from being cleaved by C5 convertase, inhibits the cleavage of C5 into C5a and C5b, and thus blocks the formation of membrane attack complex (MAC). Compound C5-IN-1 has an IC50 of 0.77 μM and 5 nM in 50% human whole blood and 2% human serum to block MAC deposition induced by zymosan, respectively. Compound C5-IN-1 can be used to study diseases related to complement overactivation, such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) .
Synonyms: ARC1905
Target:
Forschungsgebiete:
Avacincaptad pegol (ARC1905) sodium is a 40KDa PEG-conjugated aptamer. Avacincaptad pegol sodium targets complement factor 5 (C5), inhibits the cleavage of C5 into C5a and C5b, limits inflammatory stimulation and complement membrane attack complex (MAC), and is used to study age-related macular degeneration (AMD). Avacincaptad pegol sodium limits irregular cell apoptosis by targeting downstream factors in the complement cascade while preserving the early steps of the complement system .
Art. -Nr.: HY-P3502
CAS. Nr.: 1841136-73-9
Synonyms: RA101495; RA3193
Target:
Forschungsgebiete:
Art. -Nr.: HY-P99965
CAS. Nr.: 1917321-26-6
Synonyms: SKY59; RO7112689; RG-6107
Target:
Forschungsgebiete:
Art. -Nr.: HY-145720
CAS. Nr.: 1639264-46-2
Synonyms: ALN-CC5
Forschungsgebiete:
Cemdisiran (ALN-CC5) is an N-acetylgalactosamine-conjugated RNAi agent and also a complement component C5 inhibitor. Cemdisiran targets C5 mRNA, cleaves C5 mRNA via the endogenous RNA interference pathway, and inhibits the production of C5 protein in the liver. Cemdisiran exerts a dose-dependent inhibitory effect on total C5 concentrations in cynomolgus monkeys. When used in combination with Pozelimab (HY-P99786) in cynomolgus monkeys, Cemdisiran achieves a more sustained and complete inhibitory effect on complement activity. Cemdisiran can be used in the research of paroxysmal nocturnal hemoglobinuria and other complement-mediated diseases .
Art. -Nr.: HY-P99520
CAS. Nr.: 2250440-41-4
Synonyms: CaCP-29, IFX-1
Target:
Forschungsgebiete:
Art. -Nr.: HY-148457
CAS. Nr.: 1613641-69-2
Synonyms: Izervay
Target:
Forschungsgebiete:
Avacincaptad pegol (Izervay) is a selective inhibitor targeting complement component C5, and is a pegylated ribonucleic acid aptamer. Avacincaptad pegol inhibits the cleavage of C5 into pro-inflammatory C5a and C5b, which forms the membrane attack complex (C5b-9), thereby reducing inflammatory cell recruitment and retinal cell damage. Avacincaptad pegol can slow the growth of geographic atrophy (GA) lesions and reduce the risk of persistent vision loss. Avacincaptad pegol can be used in research of geographic atrophy associated with age-related macular degeneration (AMD) and has been approved by the FDA .
Art. -Nr.: HY-P99638
CAS. Nr.: 2456407-94-4
Synonyms: ALXN-1720
Target:
Forschungsgebiete:
Art. -Nr.: HY-145720A
Reinheit: 96.02%
Synonyms: ALN-CC5 sodium
Forschungsgebiete:
Cemdisiran sodium (ALN-CC5 sodium) is an N-acetylgalactosamine-conjugated RNAi agent and also a complement component C5 inhibitor. Cemdisiran sodium targets C5 mRNA, cleaves C5 mRNA via the endogenous RNA interference pathway, and inhibits the production of C5 protein in the liver. Cemdisiran sodium exerts a dose-dependent inhibitory effect on total C5 concentrations in cynomolgus monkeys. When used in combination with Pozelimab (HY-P99786) in cynomolgus monkeys, Cemdisiran sodium achieves a more sustained and complete inhibitory effect on complement activity. Cemdisiran sodium can be used in the research of paroxysmal nocturnal hemoglobinuria and other complement-mediated diseases .
Art. -Nr.: HY-160901
CAS. Nr.: 1349637-14-4
Target:
Forschungsgebiete:
CP-289,503 is an inhibitor of the complement C5a receptor with an IC50 of 1 μM. C5a acts as an activator of leukocytes and phagocytes during complement system activation. The C5a receptor can bind to C5a, which can stimulate the upregulation of cell surface integrins and degranulation of inflammatory cells, leading to endothelial cell damage. C5a receptor inhibitors can block C5a signaling and inhibit a variety of inflammatory diseases .
Art. -Nr.: HY-177094
CAS. Nr.: 2489430-53-5
Synonyms: INF056
Target:
Forschungsgebiete:
Izicopan (INF056) is a complement factor C5a receptor (C5aR1) antagonist. Izicopan inhibits C5a-induced calcium mobilization with an IC50 of 10-100 nM. Izicopan is applicable for the research of complement-mediated inflammatory responses .
Art. -Nr.: HY-P3502B
Target:
Forschungsgebiete:
Zilucoplan (PEG2) is a Zilucoplan (HY-P3502) derivative, where the linker section replaces PEG24 by PEG2. Zilucoplan is a potent complement component 5 (C5) inhibitor .
Art. -Nr.: HY-P3502A
Synonyms: RA101495 TFA; RA3193 TFA
Target:
Forschungsgebiete:
Art. -Nr.: HY-153098
Target:
Forschungsgebiete:
ARC186 (sodium) is an unconjugated 40KDa PEG aptamer with a sequence identical to HY-147080 Avacincaptad pegol (ARC1905) sodium. ARC1905 is highly potent complement inhibitors that function by blocking the convertase-catalyzed activation of C5.
Art. -Nr.: HY-P99886
CAS. Nr.: 219685-93-5
Synonyms: h5G1. 1-SC
Target:
Forschungsgebiete:
Art. -Nr.: HY-P990753
CAS. Nr.: 2763342-87-4
Synonyms: CAN-106
Target:
Forschungsgebiete:
Art. -Nr.: HY-17627R
CAS. Nr.: 1346623-17-3
Synonyms: CCX168 (Standard)
Target:
Forschungsgebiete:
Avacopan (Standard) is the analytical standard of Avacopan. This product is intended for research and analytical applications. Avacopan (CCX168) is a potent, selective and orally available complement 5a receptor (C5aR) inhibitor with an IC50 of 0.1 nM.
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
